Published by Josh White on 27th February 2020
(Sharecast News) - Hikma Pharmaceuticals reported a 6% improvement in group core revenue in its preliminary results on Thursday, to $2.2bn (£1.7bn).
URL: http://www.digitallook.com/dl/news/story/30305908/...